Skip to main content
. 2020 Feb 21;21(4):1477. doi: 10.3390/ijms21041477
CAD coronary artery disease
CV cardiovascular
CVD cardiovascular disease
ERα estrogen receptor-α
ERβ estrogen receptor-β
ERs estrogen receptors
eNOS endothelial nitric oxide synthase
FMD flow-mediated dilatation
a-FABP adipocyte fatty acid-binding protein
IHD ischemic heart disease
MACE major adverse cardiac event
MAPK mitogen-activated protein kinase
NO nitric oxide
WHO World Health organization